Diode Laser Therapy System
Sanhe LEFIS Electronics Co., Ltd. · Decision date Sep 10, 2026
What did the FDA decide?
Sanhe LEFIS Electronics Co., Ltd. received a substantially equivalent (SESE) decision for the Diode Laser Therapy System, a Class II powered laser surgical instrument under 21 CFR 878.4810, product code GEX, in the General and Plastic Surgery panel. FDA recorded the decision on September 10, 2026, on a traditional 510(k) received May 11, 2026; the submission was not reviewed by a third party and no predetermined change control plan was authorized. SE denotes 510(k) clearance, not PMA approval.
The stated indication is hair removal. The summary lists the main console, a module with optical head, cold plate and trigger, and a foot-switch, and cites the InMode Diolaze XL System (K180719) as predicate, with K192569 and K140009 as reference devices. Nonclinical testing is described against ANSI/AAMI ES60601-1 and IEC 60601-1-2. The provided excerpts do not give clinical performance data, wavelength, energy settings or full labeling, so those details remain unknown here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261562
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Sanhe LEFIS Electronics Co., Ltd.
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Applicant
- Sanhe LEFIS Electronics Co., Ltd.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K261562 received
Application receipt date recorded by FDA.
K261562 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sanhe LEFIS Electronics Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Langfang
Sources and methodology
- Original FDA record: K261562
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


